OS-127 Efficacy and Safety of Tobevibart (VIR-3434) Alone or in Combination with Elebsiran (VIR-2218) in Participants with Chronic Hepatitis Delta Virus Infection: Preliminary Results from the Phase 2 SOLSTICE Trial in Non-Cirrhotic and Compensated Cirrhotic Participants
Journal of Hepatology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined